Dale N Gerding
Overview
Explore the profile of Dale N Gerding including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
196
Citations
13253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drekonja D, Shaukat A, Huang Y, Zhang J, Reinink A, Nugent S, et al.
Clin Infect Dis
. 2024 Sep;
80(1):52-60.
PMID: 39271107
Background: Clostridioides difficile infection (CDI) is the most common cause of healthcare-associated infections in US hospitals, with 15%-30% of patients experiencing recurrence. The aim of our randomized, double-blind clinical trial...
2.
Hensen A, Vehreschild M, Gerding D, Krut O, Chen W, Young V, et al.
Clin Microbiol Infect
. 2024 Aug;
31(3):373-379.
PMID: 39214188
Background: Clostridioides difficile (C. difficile) remains the leading cause of healthcare-associated diarrhoea, posing treatment challenges because of antibiotic resistance and high relapse rates. Faecal microbiota transplantation is a novel treatment...
3.
Kuijper E, Gerding D
Clin Infect Dis
. 2024 Aug;
79(6):1512-1514.
PMID: 39178347
No abstract available.
4.
Wieczorkiewicz J, Skinner A, Cheknis A, Petrella L, Stevens V, Wright L, et al.
Antimicrob Agents Chemother
. 2024 Jul;
68(8):e0069824.
PMID: 38953622
In contrast to the epidemiology 10 years earlier at our hospital when the epidemic restriction endonuclease analysis (REA) group strain BI accounted for 72% of isolates recovered from first-episode infection...
5.
Guh A, Li R, Korhonen L, Winston L, Parker E, Czaja C, et al.
Open Forum Infect Dis
. 2024 Apr;
11(4):ofae127.
PMID: 38577028
Background: Because interventions are available to prevent further recurrence in patients with recurrent infection (rCDI), we identified predictors of multiple rCDI (mrCDI) in adults at the time of presentation with...
6.
Guh A, Fridkin S, Goodenough D, Winston L, Johnston H, Basiliere E, et al.
Infect Control Hosp Epidemiol
. 2024 Jan;
45(5):590-598.
PMID: 38268440
Objective: Patients tested for infection (CDI) using a 2-step algorithm with a nucleic acid amplification test (NAAT) followed by toxin assay are not reported to the National Healthcare Safety Network...
7.
Yokoe D, Advani S, Anderson D, Babcock H, Bell M, Berenholtz S, et al.
Infect Control Hosp Epidemiol
. 2023 Oct;
44(10):1533-1539.
PMID: 37855077
Since the initial publication of in 2008, the prevention of healthcare-associated infections (HAIs) has continued to be a national priority. Progress in healthcare epidemiology, infection prevention, antimicrobial stewardship, and implementation...
8.
Yokoe D, Advani S, Anderson D, Babcock H, Bell M, Berenholtz S, et al.
Infect Control Hosp Epidemiol
. 2023 Aug;
44(10):1540-1554.
PMID: 37606298
No abstract available.
9.
Wright L, Skinner A, Cheknis A, McBurney C, Ge L, Pacheco S, et al.
Antibiotics (Basel)
. 2023 Jul;
12(7).
PMID: 37508255
The COVID-19 pandemic was associated with increases in some healthcare-associated infections. We investigated the impact of the pandemic on the rates and molecular epidemiology of infection (CDI) within one VA...
10.